August 14, 2025 · Form 4 insider transaction
Ausiello Dennis A bought 5,153 shares of Alnylam Pharmaceuticals, Inc. at $128.31 per share, a transaction worth $661.2K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 15, 2025.